Urothelial Cancer Latest Advances

Urothelial carcinoma of the renal pelvis and ureter with shadow cell morphology: report of a case

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: September 07, 2026

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Journal: Immunotherapy

Published: September 02, 2026

Adjuvant chemotherapy vs. observation for locally advanced upper tract urothelial carcinoma following radical nephroureterectomy.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: September 01, 2026

Upper tract urothelial carcinoma - regional differences observed in several quality indicators

Journal: Lakartidningen

Published: August 31, 2026

Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.

Journal: Expert opinion on biological therapy

Published: August 29, 2026

Genomic Landscape of Metastatic Urothelial Cancer in a Multicenter Cohort From Argentina.

Journal: JCO global oncology

Published: August 27, 2026

Metastatic Urothelial Carcinoma of the Bladder to the Retina: A Clinicopathological Correlation and Review of the Literature.

Journal: Retina (Philadelphia, Pa.)

Published: August 21, 2026

Early Peritoneal-Dominant Recurrence After Robot-Assisted Radical Cystectomy for Urothelial Carcinoma.

Journal: Journal of laparoendoscopic & advanced surgical techniques. Part A

Published: August 21, 2026

SWI/SNF Alterations Define a Chromatin-Dependent Subtype of Urothelial Carcinoma.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma.

Journal: JCO oncology practice

Published: August 18, 2026

A Case Report of a 64-Year-Old Man With Urothelial Carcinoma With Brain and Leptomeningeal Metastases Treated With Intrathecal Methotrexate as Part of Multimodal Management.

Journal: The American journal of case reports

Published: August 17, 2026

Recurrent Invasive Clear Cell Subtype of Upper Tract Urothelial Carcinoma Responding to Enfortumab Vedotin and Pembrolizumab After Chemotherapy: A Case Report.

Journal: Archivos espanoles de urologia

Published: August 17, 2026

Urothelial Cancer Latest Advances

Find the Latest Research About Urothelial Cancer

Urothelial carcinoma of the renal pelvis and ureter with shadow cell morphology: report of a case

Urothelial carcinoma of the renal pelvis and ureter with shadow cell morphology: report of a case

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Adjuvant chemotherapy vs. observation for locally advanced upper tract urothelial carcinoma following radical nephroureterectomy.

Adjuvant chemotherapy vs. observation for locally advanced upper tract urothelial carcinoma following radical nephroureterectomy.

Upper tract urothelial carcinoma - regional differences observed in several quality indicators

Upper tract urothelial carcinoma - regional differences observed in several quality indicators

Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.

Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.

Genomic Landscape of Metastatic Urothelial Cancer in a Multicenter Cohort From Argentina.

Genomic Landscape of Metastatic Urothelial Cancer in a Multicenter Cohort From Argentina.

Metastatic Urothelial Carcinoma of the Bladder to the Retina: A Clinicopathological Correlation and Review of the Literature.

Metastatic Urothelial Carcinoma of the Bladder to the Retina: A Clinicopathological Correlation and Review of the Literature.

Early Peritoneal-Dominant Recurrence After Robot-Assisted Radical Cystectomy for Urothelial Carcinoma.

Early Peritoneal-Dominant Recurrence After Robot-Assisted Radical Cystectomy for Urothelial Carcinoma.

SWI/SNF Alterations Define a Chromatin-Dependent Subtype of Urothelial Carcinoma.

SWI/SNF Alterations Define a Chromatin-Dependent Subtype of Urothelial Carcinoma.

Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma.

Real-World Toxicity and Efficacy Profile of Enfortumab Vedotin With or Without Pembrolizumab in Ultra-Elderly Patients With Advanced Urothelial Carcinoma.

A Case Report of a 64-Year-Old Man With Urothelial Carcinoma With Brain and Leptomeningeal Metastases Treated With Intrathecal Methotrexate as Part of Multimodal Management.

A Case Report of a 64-Year-Old Man With Urothelial Carcinoma With Brain and Leptomeningeal Metastases Treated With Intrathecal Methotrexate as Part of Multimodal Management.

Recurrent Invasive Clear Cell Subtype of Upper Tract Urothelial Carcinoma Responding to Enfortumab Vedotin and Pembrolizumab After Chemotherapy: A Case Report.

Recurrent Invasive Clear Cell Subtype of Upper Tract Urothelial Carcinoma Responding to Enfortumab Vedotin and Pembrolizumab After Chemotherapy: A Case Report.